The iStent is the first FDA approved “trabecular microbypass device.” These devices aim to shunt aqueous fluid directly from the anterior chamber into Schlemm’s canal. Learn More about it
Multiple studies have looked into its effect on both chronic open angle glaucoma as well as normal tension glaucoma. The evidence suggests that its use may slow visual field loss.
So how long has canaloplasty been around? Since 2008? Or, could you argue that its origins go back as far as 1968 (almost 50 years ago)?
An exciting new class of potential glaucoma medications include what are termed the ROCK and ROCK/NET inhibitors. And it’s about time! Twenty years have passed since the last new class of medications (prostaglandin analogs) were approved for the treatment of glaucoma.